Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.
It looks like she has opted out on making any decisions where there is a conflict of interest with her husbands business and it wouldn't be a justifiable reason to deny people access to the funding so hopefully that was taken into consideration before she was appointed.
https://inews.co.uk/news/new-health-secretary-husbands-business-2753869
The Chancellor is being urged to bring forward special fund for medical cannabis in his Autumn statement and i like the response from Penny Mordaunt.
Ms Mordaunt added: “I will immediately after this session … contact the Department of Health, will contact through my PPS (parliamentary private secretary), the Secretary of State for Health and make her aware of this situation.
“We appreciate that we cannot make clinical decisions on behalf of individual patients.
“But what we can ensure is that if a drug or medical device could benefit a patient that the systems are in place to ensure that they get access to it – even if it is not a Nice (National Institute for Health and Care Excellence) approved treatment, people in this country still have that right.
“We will facilitate an immediate meeting with the Department of Health and I will be kept informed of progress on this matter.”
https://www.independent.co.uk/news/uk/natalie-elphicke-penny-mordaunt-chancellor-nhs-jeremy-hunt-b2448476.html
Good news as the company are looking to expand the access to Treat It digital consultation service through UK pharmacies then securing this contract extension looks to be a very important step and as mentioned in their Half Year Results as stated below.
Partnership with UK high street pharmacies - undertake a pilot programme that will see Kanabo collaborate with physical high street pharmacies to trial in-pharmacy consultations via our Treat It clinic, tapping into the pharmacies' existing patient networks to broaden Kanabo's outreach and addressable market.
There were 2 bigger UNKOWN trades declared on 4th Sept for over 4 million shares and you would expect thats part of the reason for the decline in the share price but only if they were sells other than that make your own mind up about what's been happening.
Good to see the CEO being interviewed on mainstream TV
https://www.youtube.com/watch?v=8pOjScovt2E
Looks very promising and more products to come
https://cannabishealthnews.co.uk/2023/11/02/uk-patients-gain-new-pain-management-options-through-innovative-partnership-between-british-cannabis-and-kanabo-groups-treat-it-clinic/
A questionnaire has been released by the Guardian newspaper aimed at ONLY prescribed Medical Cannabis users and their experiences with the police. So it looks like there is an aim to provide extra protection for legal users as the UK work towards expanding on clarity to the legislation thats already in place .
https://www.theguardian.com/society/2023/oct/13/uk-medical-cannabis-patients-tell-us-about-your-experiences-with-police
Seems like there will be lots of activities going on throughout this week and hopefully more media coverage too.
https://cannabishealthnews.co.uk/2023/10/03/medical-cannabis-awareness-week-returns-for-5th-anniversary-of-law-change/
The MMs have been slowly reducing the price together with someone offloading in drabs but IMO it looks orchestrated and nothing to do with the real value.Still a great buying opportunity whilst the sector is still under the radar.
Heapseal If the barrel of oil was above $91 then based on these results the cash position would be higher.However I see your point but we never know exactly how the cash is spent but IMO the results look better than some expected
These are not too bad results considering the average price of $67 per barrel and even those the last drill may have not met the expectations of some there is a reduced operating loss and a increased cash position whilst they have the ability to fund their future projects so it still looks positive going forward
These results show that things are coming together including a reduced operating loss so a slower cash burn that allows more opportunities to expand the Treat It platform in a partnership with UK pharmacies. Even though they have not yet received CE mark certification they have committed to say they have completed all the necessary stages towards gaining it.So their positive outlook for growth looks encouraging.
Still way off the predictions of 1000 bpd but its still progress and now move on to the next drill..
They are stocked up again so hopefully its followed by an update .
Sapphire Medical Cannabis clinic ( CURALEAF )are now advertising on Sky NewsUK Channel and their platform is very similar to Treat It . Maybe in the near future we could see Treat It ads too as it looks like the advertising restrictions are being relaxed
https://www.sapphireclinics.com/pricing/
https://chamberagency.co.uk/sapphire-clinics-tv-advert-medicinal-cannabis/
I saw this discussion that was well represented by the 2 mothers as well the Professor and if Rishi Sunak does not get a grip on this then you will find Labour will pick it up as one of their political goals because of the wider aspect of patients being denied NHS access to treat other illnesses as well as epilepsy. Now with constant tv coverage the media are making it more harder for the government to ignore. Hopefully Kanabo has positioned itself to quickly respond if the government make any commitments to improve access as its harder for them to deny as the evidence is already out there .
The NHS has published the CBPM's guidelines that shows their support for the sector has advanced
https://www.england.nhs.uk/long-read/cannabis-based-products-for-medicinal-use-cbpms/
Over in the US stock prices in the sector have been rising as the support grows so things are still looking positive despite the low prices we see here and a great buying opportunity as they are trading way below the latest raise price.
Depending on how much stock they previously had then this looks to be good news and shows the demand for their products. If right then they need to ensure they have enough stock as the growth of sales from their different platforms looks to be gaining traction. It will be interesting to see if this issue is reflected in their next half year report.
https://kanabo.store
The price is slowly dropping but the sector is taking shape and looking more promising despite the current silence period. Hopefully we should have some good news soon to support. and justify the 50% dilution
https://www.bbc.co.uk/news/world-us-canada-66667191